Plasmid– tag –
-
MaxCyte & VectorBuilder Partner on Virus-Free Gene Delivery Platform for Ex Vivo Cell Therapies, Boosting CAR T-Cell Manufacturability
BioProcess International USA Overview CDMO VectorBuilder and MaxCyte have partnered to develop a virus-free gene delivery platform for ex vivo cell therapies, including CAR T cells. This collaboration integrates VectorBuilder's 'MiniVec'... -
Genedata Establishes New Standard for Biopharma Quality Control with NGS, Ensuring Genetic Stability in CGT
Genedata Switzerland Overview Genedata highlights Next-Generation Sequencing (NGS) as a powerful analytical tool for biopharmaceutical quality control (QC). NGS offers GxP-compliant workflows and supports data integrity and streamlined c... -
Qihan Biotech Receives FDA RMAT and Breakthrough Therapy Designations for Universal Dual-Target CAR-T Therapy, Supported by PackGene Biotech’s CDMO Expertise
PackGene Biotech China Overview Qihan Biotech announced that its universal dual-target CAR-T therapy received both Regenerative Medicine Advanced Therapy (RMAT) and Breakthrough Therapy designations from the U.S. FDA. PackGene Biotech, a... -
AGC Biologics & Asimov Revolutionize Viral Vector Manufacturing with Single-Plasmid Lentiviral Edge Packaging Cell Line License
MetaphysicalCells Unknown Overview AGC Biologics and Asimov have licensed Asimov's pre-engineered Lentiviral (LV) Edge Packaging cell line, poised to revolutionize viral vector manufacturing. AGC Biologics' Milan facility can now produce... -
Aldevron and Minaris Renew Lentiviral Plasmid Agreement, Bolstering Critical Supply for Advanced Cell and Gene Therapies
BioBuzz USA Overview Aldevron and Minaris have renewed their lentiviral plasmid licensing agreement, significantly expanding access to scalable plasmid solutions essential for advanced cell and gene therapy (CGT) developers. This collabo...
12